Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 2/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 2/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | NAMPT | P43490 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vesnarinone SCHEMBL29402965 | 1.00 | PDE3B (1.00) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| Vesnarinone SCHEMBL6243858 | 1.00 | PDE3B (1.00) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| Vesnarinone SCHEMBL4221551 | 0.94 | PDE3B (0.89) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| SCHEMBL8495619 | 0.92 | PDE3B (0.85) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| SCHEMBL11042336 | 0.92 | NR3C1 (0.84) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| SCHEMBL9824612 | 0.91 | PDE3B (0.83) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| SCHEMBL8498282 | 0.90 | PDE3B (0.81) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| SCHEMBL7269908 | 0.88 | SLC6A4 (0.78) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| SCHEMBL11202820 | 0.88 | NR3C1 (0.78) | PDE3BPDE3ANR3C1PGRSLC6A4 | |
| Water SCHEMBL11200345 | 0.87 | NR3C1 (0.76) | PDE3BPDE3ANR3C1PGRSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15205 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12364682-B2 | Use of tegaserod in preparation of anti-tumor drug | QINGDAO HAIJI BIOMEDICINE CO., LTD. (CN) | 2025-07-22 | — | — | US | claimed |
| US-20250059301-A1 | Fusion Protein Construct | NORTHWESTERN UNIVERSITY | 2025-02-20 | — | — | US | claimed |
| US-11903992-B2 | Composition comprising lidocaine, l-carnosine and dexpanthenol | CELLIX BIO PRIVATE LIMITED (IN) | 2024-02-20 | — | — | US | claimed |
| US-20230111925-A1 | FIBROTIC DISEASE MECHANISM AND THERAPEUTIC DRUG THEREFOR | GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER (CN) | 2023-04-13 | — | — | US | claimed |
| WO-2022190030-A1 | A TOPICAL FORMULATION FOR THE TREATMENT OF SKIN DISEASES | AVACA PHARMA PRIVATE LIMITED (IN) | 2022-09-15 | — | — | WO | claimed |
| US-20220233629-A1 | COMPOSITION COMPRISING LIDOCAINE, L-CARNOSINE AND DEXPANTHENOL | CELLIX BIO PRIVATE LIMITED (IN) | 2022-07-28 | — | — | US | claimed |
| WO-2022157587-A1 | A COMPOSITION COMPRISING LIDOCAINE, L-CARNOSINE AND DEXPANTHENOL | CELLIX BIO PRIVATE LIMITED (IN) | 2022-07-28 | — | — | WO | claimed |
| WO-2022123511-A1 | A COMPOSITION COMPRISING FEXOFENADINE | CELLIX BIO PRIVATE LIMITED (IN) | 2022-06-16 | — | — | WO | claimed |
| US-20220184052-A1 | COMPOSITION COMPRISING FEXOFENADINE | CELLIX BIO PRIVATE LIMITED (IN) | 2022-06-16 | — | — | US | claimed |
| EP-2704560-B1 | ORGAN CARE SOLUTION FOR EX-VIVO MACHINE PERFUSION OF DONOR LUNGS | TRANSMEDICS INC (US) | 2022-04-06 | — | — | EP | claimed |
| WO-2000078971-A2 | ATP BINDING CASSETTE TRANSPORTER PROTEIN ABC1 POPYPEPTIDES | CV THERAPEUTICS, INC. (US) | 2000-12-28 | — | — | WO | claimed |
| US-6156753-A | Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction | VIVUS, INC. (US) | 2000-12-05 | — | — | US | claimed |
| US-6110471-A | ADMINISTERING PHOSPHODIESTERASE FOR INHIBITION OF THE CYCLES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-08-29 | — | — | US | claimed |
| EP-1028690-A2 | LUTEINISING HORMONE ANTAGONISTS USEFUL FOR TREATMENT OF ESTROGEN DEFICIENCIES, OR AS A CONTRACEPTIVE | NOVO NORDISK A/S (DK) | 2000-08-23 | — | — | EP | claimed |
| WO-2000018409-A1 | USE OF CERTAIN DRUGS FOR TREATING NERVE ROOT INJURY | A+ SCIENCE INVEST AB (SE) | 2000-04-06 | — | — | WO | claimed |
| WO-1999020223-A2 | LUTEINISING HORMONE ANTAGONISTS USEFUL FOR TREATMENT OF ESTROGEN DEFICIENCIES, OR AS A CONTRACEPTIVE | NOVO NORDISK A/S (DK) | 1999-04-29 | — | — | WO | claimed |
| US-5521185-A | CARBOSYTRIL DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-28 | — | — | US | claimed |
| EP-0638311-A1 | REJECTION INHIBITOR FOR TRANSPLANTS AND IL-1 PRODUCTION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-02-15 | — | — | EP | claimed |
| CN-1063686-A | With the synthetic vesnarinone of active ester method | MEDICINE INST HUAXI MEDICAL UN (CN) | 1992-08-19 | — | — | CN | claimed |
| US-4415572-A | CARDIOTONIC AND INOTROPIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1983-11-15 | — | — | US | claimed |